Pacific Edge says US medical and legal tides have turned in its favour

Pacific Edge says US medical and legal tides have turned in its favour
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Greg Hurrell
Pacific Edge is confident its newly announced $20 million capital raise, combined with new research results and professional validation, will keep it in the bladder cancer testing game.Chief executive Peter Meintjes says a clinical endorsement from the American Urological Association (AUA) should give it the medical and legal clout to regain Medicare coverage for its bladder cancer tests in the US.The dual NZX and ASX-listed medical technology company reported a net loss of $29.9m in the 12 months to March 31, 2025, compared with $29.5m in the...

More Markets

NZ sharemarket edges higher as F&P Healthcare weighs on gains
Markets Market Close

NZ sharemarket edges higher as F&P Healthcare weighs on gains

The S&P/NZX 50 Index closed 14.49 points or 0.11% down at 13,391.59.

Jamie Gray 24 Oct 2025
Contact Energy expands global investor base
Markets

Contact Energy expands global investor base

Contact Energy priced an inaugural €500 million (NZ$1.01b) 7-year senior bond under its Euro Medium Term Note (EMTN) Programme, it said Friday.“This marks a milestone in Contact’s funding strategy, expanding our global investor base and reinforcing our commitment to sustainable f...

Rebecca Howard 24 Oct 2025
Kiwibank wary of capital-review barrier to growth
Finance

Kiwibank wary of capital-review barrier to growth

Kiwibank raises issues of competitive advantage.

Andy Macdonald 24 Oct 2025
Fonterra windfall brings risks: ASB
Primary Sector

Fonterra windfall brings risks: ASB

Farmers will vote for the Lactalis deal on Oct 30.

Rebecca Howard 24 Oct 2025